Avian Bird Flu - Novartis Flu Vaccine Gets Positive Opinion From European Union

Novartis Flu Vaccine Gets Positive Opinion From European Union
WebWire - Basel - Novartis has announced that it has received a positive opinion supporting European Union regulatory approval of the human vaccine Focetria for use in the event of an pandemic influenza outbreak, such as one that could be caused by the H5N1

Biotech Iomai seeks almost $32 million in private placement
Washington Business Journal - In January, Iomai got another dose of funding through a contract from the U.S. Department of Health and Human Services to develop a skin patch that releases vaccine doses to protect against pandemic influenza. Initially worth $14.5 million, the

Health Care In Developing Countries Could Be Greatly Improved By
Medical News Today - His contributions have included improvements in quality end of life care, fair priority setting in healthcare organizations, teaching bioethics, pandemic influenza planning, global biosecurity, and harnessing life sciences and emergent technologies

US Overdue For Bird Flu Experts Warn
Terra Daily - The threat of avian influenza has returned. But public-health officials at the recent 2007 Seasonal and Pandemic Influenza conference said the risk never left. In fact, the chances for such an outbreak have only increased. In an interview with United

Area calendar
Pantagraph - Pandemic Influenza: Preparedness Prevents Panic," 2007 Scholar in Health Education lecture by Audrey R. Gotsch; 7 p.m., Bone Student Center Circus Room, Illinois State University, Normal. For kids -- Registration starts for Normal residents for Lapsit

GSK's Vaccine Protects Against Bird Flu
INS News - The data confirm that our pre-pandemic influenza vaccine has the ability to recognize and kill an H5N1 strain that is different to the one contained in the vaccine, said Jean Stephenne, president of GlaxoSmithKline Biologicals, the company's vaccine